Clinical trials
Completed Phase 1 trials in Taiwan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
268 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2002 | 2 |
| 2004 | 1 |
| 2005 | 4 |
| 2006 | 3 |
| 2007 | 4 |
| 2008 | 8 |
| 2009 | 14 |
| 2010 | 5 |
| 2011 | 14 |
| 2012 | 16 |
| 2013 | 16 |
| 2014 | 18 |
| 2015 | 27 |
| 2016 | 23 |
| 2017 | 17 |
| 2018 | 23 |
| 2019 | 11 |
| 2020 | 24 |
| 2021 | 12 |
| 2022 | 8 |
| 2023 | 11 |
| 2024 | 3 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 268 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 23 |
| National Taiwan University Hospital | 16 |
| Boehringer Ingelheim | 11 |
| Hoffmann-La Roche | 11 |
| China Medical University Hospital | 9 |
| AstraZeneca | 8 |
| Janssen Research & Development, LLC | 7 |
| AbbVie | 6 |
| Amgen | 6 |
| National Health Research Institutes, Taiwan | 6 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasms | 33 |
| Carcinoma, Non-Small-Cell Lung | 27 |
| Carcinoma, Hepatocellular | 15 |
| Breast Neoplasms | 14 |
| Hepatitis B, Chronic | 12 |
| Stomach Neoplasms | 12 |
| Colorectal Neoplasms | 11 |
| Squamous Cell Carcinoma of Head and Neck | 9 |
| COVID-19 | 8 |
| Lung Neoplasms | 8 |
Trials
Showing 1 to 25 of 268. Each trial links to its page on Pharma Observatory.
168 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.